Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03650621




Registration number
NCT03650621
Ethics application status
Date submitted
26/06/2018
Date registered
29/08/2018

Titles & IDs
Public title
Acupuncture for Preterm Infants Requiring Eye-exam
Scientific title
Magnetic Non-Invasive Acupuncture For Infant Comfort A Pilot Study in Preterm Infants Requiring Eye-exam for Retinopathy of Prematurity
Secondary ID [1] 0 0
Pro00080714
Universal Trial Number (UTN)
Trial acronym
MAGNIFIC-ROP
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Retinopathy of Prematurity 0 0
Pain 0 0
Acupuncture 0 0
Premature Infant 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye
Reproductive Health and Childbirth 0 0 0 0
Complications of newborn
Reproductive Health and Childbirth 0 0 0 0
Childbirth and postnatal care
Reproductive Health and Childbirth 0 0 0 0
Fetal medicine and complications of pregnancy

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Magnetic acupuncture
Treatment: Devices - stickers (magnets removed)

Experimental: Intervention - Magnetic acupuncture - Infants randomized to the intervention arm will have 5 magnetic stickers placed on both ears approximately 1 hour before the eye-exam and will stay in place for approximately 1 hour after the eye-exam.

Total duration of study 2.5-3 hours

Placebo comparator: Control - Placebo control - In this arm the infants will have 5 stickers (magnets removed) placed on their ear approximately 1 hour before the eye-exam and will stay in place for approximately 1 hour after the eye-exam.

Total duration of study 2.5-3 hours


Treatment: Devices: Magnetic acupuncture
5 magnetic acupuncture stickers will be placed on the infants ear

Treatment: Devices: stickers (magnets removed)
in this group 5 stickers (magnets removed) will be placed on the infants ear
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Changes in Premature Infant Pain Profile (PIPP) scores
Timepoint [1] 0 0
Comparison of baseline (= 1 hour before eye-exam) and after eye-exam (1 hour after)
Secondary outcome [1] 0 0
Heart rate changes
Timepoint [1] 0 0
changes in heart rate in beats per minute 1 hour before and 1 hour after eye-exam
Secondary outcome [2] 0 0
Changes in oxygen saturation
Timepoint [2] 0 0
changes in oxygen saturation in % 1 hour before and 1 hour after eye-exam
Secondary outcome [3] 0 0
changes in cerebral oxygenation
Timepoint [3] 0 0
changes in cerebral oxygenation % 1 hour before and 1 hour after eye-exam

Eligibility
Key inclusion criteria
* Infants weighing less than 1250g at birth admitted into the NICU at the Royal Alexandra Hospital will require routine,regularly scheduled ROP eye-exams beginning at 32 weeks corrected age. We will not enroll any infant who meets any exclusion criteria.
Minimum age
29 Weeks
Maximum age
36 Weeks
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Chronic pain stimuli (e.g. infants who have had recent surgery)
2. Neurological problems that could impair pain perception (e.g. diagnosis of intraventricular hemorrhages Grade III or greater)
3. Cardiorespiratory problems that could impair oxygenation (e.g. any infant who is intubated and requiring mechanical ventilation)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
24/08/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
30/04/2020
Sample size
Target
Accrual to date
Final
100
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
University of Sydney - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
Canada
State/province [1] 0 0
Alberta
Country [2] 0 0
Malaysia
State/province [2] 0 0
Kuala Lumpur

Funding & Sponsors
Primary sponsor type
Other
Name
University of Alberta
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Georg Schmolzer, MD, PhD
Address 0 0
University of Alberta
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?


Supporting document/s available: Study protocol, Statistical analysis plan (SAP), Informed consent form (ICF)
When will data be available (start and end dates)?
once study has been completed
Available to whom?
email to PI
Available for what types of analyses?
How or where can data be obtained?


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT03650621